[go: up one dir, main page]

FI893467L - Förfarande för framställning av som läkemedel användbara derivat av 4-oxokinolin-3-karboxylsyra - Google Patents

Förfarande för framställning av som läkemedel användbara derivat av 4-oxokinolin-3-karboxylsyra Download PDF

Info

Publication number
FI893467L
FI893467L FI893467A FI893467A FI893467L FI 893467 L FI893467 L FI 893467L FI 893467 A FI893467 A FI 893467A FI 893467 A FI893467 A FI 893467A FI 893467 L FI893467 L FI 893467L
Authority
FI
Finland
Prior art keywords
oxoquinoline
pharmaceuticals
preparing
carboxylic acid
acid derivatives
Prior art date
Application number
FI893467A
Other languages
English (en)
Finnish (fi)
Other versions
FI95130C (sv
FI893467A0 (sv
FI95130B (sv
Inventor
Masayuki Iwata
Tomio Kimura
Teruhiko Inoue
Yoshimi Fujihara
Tetsushi Katsube
Original Assignee
Ube Industries
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ube Industries, Sankyo Co filed Critical Ube Industries
Publication of FI893467A0 publication Critical patent/FI893467A0/sv
Publication of FI893467L publication Critical patent/FI893467L/sv
Application granted granted Critical
Publication of FI95130B publication Critical patent/FI95130B/sv
Publication of FI95130C publication Critical patent/FI95130C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI893467A 1988-07-20 1989-07-18 Förfarande för framställning av som läkemedel användbara derivat av 4-oxokinolin-3-karboxylsyra FI95130C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP18055788 1988-07-20
JP18055788 1988-07-20
JP22422088 1988-09-07
JP22422088 1988-09-07

Publications (4)

Publication Number Publication Date
FI893467A0 FI893467A0 (sv) 1989-07-18
FI893467L true FI893467L (sv) 1990-01-21
FI95130B FI95130B (sv) 1995-09-15
FI95130C FI95130C (sv) 1995-12-27

Family

ID=26500036

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893467A FI95130C (sv) 1988-07-20 1989-07-18 Förfarande för framställning av som läkemedel användbara derivat av 4-oxokinolin-3-karboxylsyra

Country Status (14)

Country Link
US (4) US5348961A (sv)
EP (2) EP0352123B1 (sv)
KR (2) KR950010325B1 (sv)
CN (1) CN1028226C (sv)
AT (2) ATE117295T1 (sv)
AU (1) AU618823B2 (sv)
CA (1) CA1335670C (sv)
DE (2) DE68929330T2 (sv)
DK (1) DK175617B1 (sv)
ES (1) ES2070175T3 (sv)
FI (1) FI95130C (sv)
GR (1) GR3015818T3 (sv)
IE (1) IE68941B1 (sv)
NO (1) NO175256C (sv)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
DE4015299A1 (de) * 1990-05-12 1991-11-14 Bayer Ag Verfahren zur herstellung von 3-amino-2-(het)-aroyl-acrylsaeurederivaten
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
JP3165742B2 (ja) * 1991-07-16 2001-05-14 中外製薬株式会社 キノロンカルボン酸誘導体の製造方法
EP0545866A1 (de) * 1991-12-06 1993-06-09 Ciba-Geigy Ag Verfahren zur Herstellung von Trifluorbenzolderivaten
CA2102196A1 (en) * 1992-05-26 1993-11-27 Terumitsu Kaihoh 5-aminoquinolone carboxylic acid derivative and antibacterial agent containing the same as active ingredient
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
DE4232505A1 (de) * 1992-09-29 1994-03-31 Degussa Verfahren zur Reduktion von Carbonsäuren oder Carbonsäurederivaten sowie neue Verbindungen
CA2152828A1 (en) * 1993-03-16 1994-07-07 Shin-Ichi Uesato 8-methoxy-quinolonecarboxylic acid derivatives
FR2706459B1 (fr) * 1993-06-17 1995-08-04 Bouchara Sa Nouveaux dérivés quinoloniques, leur procédé d'obtention et les compositions pharmaceutiques qui en contiennent.
US6964611B2 (en) * 1996-12-30 2005-11-15 Walker Digital, Llc System and method for automated play of lottery games
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
AU735186B2 (en) 1997-09-15 2001-07-05 Warner Chilcott Company, Llc Antimicrobial quinolones, their compositions and uses
US6531624B1 (en) 1998-11-18 2003-03-11 Asahi Glass Company Ltd. Aminoacrylic acid derivatives and process for producing the same
US20010018446A1 (en) 1999-09-23 2001-08-30 G.D. Searle & Co. Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US7176313B2 (en) * 2000-02-09 2007-02-13 Daiichi Pharmaceutical Co., Ltd. Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient
US6964966B2 (en) * 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6878713B2 (en) 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
BR0318460A (pt) 2003-09-04 2006-09-12 Wockhardt Ltd sal de arginina de ácido benzoquinolizina-2-carboxìlico tetrahidratado
WO2005026145A2 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
ES2232309B1 (es) * 2003-11-13 2006-08-01 Quimica Sintetica, S.A. Procedimiento simplificado para la obtencion de gatifloxacino.
DE102004035203A1 (de) 2004-07-21 2006-02-16 Bayer Healthcare Ag Substituierte Chinolone
DE102006005861A1 (de) 2006-02-09 2007-08-23 Aicuris Gmbh & Co. Kg Substituierte Chinolone III
ES2284380B1 (es) * 2006-03-10 2008-11-01 Quimica Sintetica S.A. Procedimiento para la preparacion de moxifloxacino y moxifloxacino clorhidrato.
AU2007230630B2 (en) * 2006-03-28 2012-12-20 Taigen Biotechnology Co., Ltd Malate salts, and polymorphs of (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
EP1999125A2 (en) * 2006-03-28 2008-12-10 The Procter and Gamble Company A coupling process for preparing quinolone intermediates
EP1999106B1 (en) * 2006-03-28 2012-06-27 TaiGen Biotechnology Co., Ltd. A hydride reduction process for preparing quinolone intermediates
CN100415212C (zh) * 2006-07-21 2008-09-03 哈药集团制药总厂 一种含乳酸卡德沙星的口服制剂
WO2008144536A1 (en) 2007-05-17 2008-11-27 Walker Digital, Llc Group play of lottery game
CN101775005B (zh) * 2009-01-13 2013-12-04 江苏恒瑞医药股份有限公司 盐酸卡屈沙星i型结晶及其制备方法
CN108129404B (zh) * 2018-01-30 2020-05-01 凯瑞斯德生化(苏州)有限公司 手性哌嗪酮衍生物的合成方法
CN108299317A (zh) * 2018-03-20 2018-07-20 爱斯特（成都）生物制药股份有限公司 1,4-二氮杂螺[5,5]十一烷盐酸盐的合成方法
CN108840814B (zh) * 2018-07-24 2021-09-24 南京药石科技股份有限公司 一种8-氧代-2,6,9-三氮杂螺[4.5]癸烷-2-羧酸叔丁酯制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
JPS62205060A (ja) * 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd ８位置換キノロンカルボン酸誘導体
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
FI871419L (fi) * 1986-03-31 1987-10-01 Sankyo Co Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning.
US4803205A (en) * 1987-08-07 1989-02-07 Warner-Lambert Company Quinolones as antibacterial agents
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent

Also Published As

Publication number Publication date
AU618823B2 (en) 1992-01-09
NO175256C (no) 1994-09-21
DE68929330D1 (de) 2001-11-08
EP0352123A2 (en) 1990-01-24
EP0352123A3 (en) 1990-09-05
GR3015818T3 (en) 1995-07-31
NO892952D0 (no) 1989-07-19
EP0610958B1 (en) 2001-10-04
CN1040977A (zh) 1990-04-04
FI95130C (sv) 1995-12-27
KR950011396B1 (ko) 1995-10-02
NO892952L (no) 1990-01-22
DE68929330T2 (de) 2002-07-04
DK175617B1 (da) 2004-12-27
KR950010325B1 (ko) 1995-09-14
ATE206401T1 (de) 2001-10-15
US5348961A (en) 1994-09-20
DE68920654T2 (de) 1995-08-31
CA1335670C (en) 1995-05-23
DK359289D0 (da) 1989-07-19
IE68941B1 (en) 1996-07-24
EP0610958A3 (en) 1995-03-22
US5436367A (en) 1995-07-25
AU3821889A (en) 1990-01-25
FI893467A0 (sv) 1989-07-18
US5496951A (en) 1996-03-05
CN1028226C (zh) 1995-04-19
EP0610958A2 (en) 1994-08-17
KR900001686A (ko) 1990-02-27
US5073556A (en) 1991-12-17
NO175256B (no) 1994-06-13
DK359289A (da) 1990-01-21
DE68920654D1 (de) 1995-03-02
FI95130B (sv) 1995-09-15
ATE117295T1 (de) 1995-02-15
EP0352123B1 (en) 1995-01-18
IE892340L (en) 1990-01-20
ES2070175T3 (es) 1995-06-01

Similar Documents

Publication Publication Date Title
FI893467L (sv) Förfarande för framställning av som läkemedel användbara derivat av 4-oxokinolin-3-karboxylsyra
FI885623A7 (sv) Förfarande för framställning av substituerande propan-fosfinsyraföreningar, användbara som läkemedel
FI871294L (sv) Förfarande för framställning av som läkemedel användbara derivat av milbemycin
FI906438L (sv) Förfarande för framställning av nya, terapeutiskt användbara A-nor-steroid-3-karboxylsyraderivat
FI874451L (sv) Förfarande för framställning av som läkemedel användbara dihydropyridinderivat
FI882369A7 (sv) Förfarande för framställning av såsom läkemedel användbara piperidinderivat
FI882716A7 (sv) Förfarande för framställning av ett som läkemedel användbart piperidinderivat eller dess farmaceutiska salt
FI891021A7 (sv) Derivat av triazol, framstaellning och anvaendning av dessa som svampdoedande medel
FI892881A7 (sv) Förfarande för framställning av terapeutiskt användbara aminosyraderivat
FI894217L (sv) Förfarande för framställning av 1-adamantanderivat
FI883249A7 (sv) Förfarande för framställning av terapeutiskt användbara 3-desmetylmevalonsyraderivat
PT88596A (pt) Process for preparing 2-anilinopyrimidine derivatives useful aspesticidas
KR860005811A (ko) 티아졸리딘디온 유도체의 제조방법
FI864560L (sv) Förfarande för framställning av nya insulinderivat
FI893361L (sv) Förfarande för framställning av ACAT-inhiberande kinolinderivat
FI895766A7 (sv) Förfarande för framställning av nya lysosfingolipider
FI893297A7 (sv) Förfarande för framställning av som läkemedel användbara (aza)naftalensultamderivat
FI874865L (sv) Förfarande för framställning av såsom läkemedel användbara imidazoldinonderivat
FI861655L (sv) Förfarande för framställning av griseolinsyraderivat som används som läkemedel
FI871022A7 (sv) Förfarande för framställning av ett som läkemedel användbart difenylmetanderivat
FI863776A7 (sv) Förfarande för framställning av 7-aminomitosanderivat.
FI884968A7 (sv) Förfarande för framställning av derivat av oktahydronaftalenoxim som är användbara som läkemedel
FI955993L (sv) Förfarande för framställning av N-acetylneuraminsyraderivat
FI875102L (sv) Analogiförfarande för framställning av ett såsom läkemedel användbart imidazolderivat
FI893003L (sv) Förfarande för framställning av terapeutiskt användbara neplanocinderivat

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: UBE INDUSTRIES LIMITED

Owner name: SANKYO COMPANY LIMITED

MA Patent expired